Aktiia, a pioneer in optical blood pressure monitoring, announced today that it has received U.S. Food and Drug ...

Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure ...

Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...

The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.

The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo ...

But there are also some risk factors for high blood pressure that aren't as well known, Syal said. Sleep apnea is a condition ...

Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and Wellington Partners, with new ...

Hilo (formerly known as Aktiia), has raised $42m (SFr34.7m) in an oversubscribed Series B funding round, bringing its total funding to more than $100m. The Swiss 24/7 blood pressure monitoring ...

Neuchâtel, Switzerland-based Aktiia said its G0 Blood Pressure Monitoring System will be available in the U.S. in 2026.

Headquartered in Switzerland, Hilo continues to expand its global presence, transforming how blood pressure is understood and managed. The Hilo system by itself is not intended to make diagnoses.

With fresh funding round, the health tech pioneer continues to work toward managing the world's blood pressure. LONDON, May 2, 2025 /PRNewswire/ -- Aktiia, a blood pressure intelligence platform ...